Prevalence of Extended Spectrum Betalactamase (ESBL) and Metallobetalactamase (MBL) Producing Pseudomonas aeruginosa and Acinetobacter baumannii Isolated from Various Clinical Samples

Table 1

Antimicrobial susceptibility of P. aeruginosa (N=192) in relation to various sampling sites.

Name of Antibiotic	Pus; (54)	Urine; (54)	Blood; (4)	Tracheal Aspirate; (29)	Endotracheal secretions; (20)	High vaginal swabs & Ear swabs; (17)	Various Body fluids; (4)	Sputum; (10)
Ceftazidime	46.3%	42.6%	50.0%	13.8%	25.0%	58.8%	50.0%	40.0%
Cefepime	29.6%	59.3%	50.0%	20.7%	30.0%	70.6%	50.0%	50.0%
Piperacillin-Tazobactum	61.1%	81.5%	75.0%	41.4%	55.0%	70.6%	75.0%	60.0%
Aztreonam	55.6%	59.3%	50.0%	10.3%	20.0%	41.2%	50.0%	60.0%
Gentamicin	61.1%	68.5%	50.0%	20.7%	25.0%	82.4%	50.0%	80.0%
Amikacin	75.9%	70.4%	50.0%	20.7%	35.0%	82.4%	50.0%	70.0%
Netilmicin	70.4%	81.5%	50.0%	24.1%	40.0%	76.5%	75.0%	50.0%
Norfloxacin	NT	48.1%	NT	NT	NT	NT	NT	NT
Ciprofloxacin	70.4%	NT	75.0%	24.1%	40.0%	88.2%	50.0%	60.0%
Imipenem	79.6%	90.7%	75.0%	27.6%	45.0%	82.4%	100.0%	40.0%
Meropenem	79.6%	70.4%	50.0%	27.6%	30.0%	88.2%	100.0%	30.0%
Polymixin B	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%
Colistin	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%